NEW YORK (GenomeWeb) – Invitae reported after the close of the market Monday that its first quarter revenues climbed 158 percent year over year, falling short of the consensus Wall Street estimate on the top line but beating the estimate on the bottom line.

The San Francisco-based genetic testing firm posted revenues of $10.3 million for the three-month period ended March 31, 2017, compared with $4 million for the first quarter of 2016. Despite the strong growth, the firm still fell shy of analysts' consensus estimate of $10.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.